Pharmaceutical

Seven hospital associations cast doubt on whether HRSA's seven-day turnaround is enough time to consider and implement stakeholder feedback before clo...

Argenx has found a new doubles partner for its work to raise awareness of myasthenia gravis.

The drug, ianalumab, met its objectives in two Phase 3 studies in Sjögren’s syndrome, boosting the outlook of a multibillion-dollar deal that hadn’t y...

With a strong launch underway for a bladder cancer gene therapy, Ferring Pharmaceuticals is finding the kind of commercial success that’s eluded many...

A regimen involving the company’s shot failed a Phase 3 trial “by a hair,” an executive said, leading the company to believe it still could win U.S. a...

New treatment option now available across all UK nations New treatment option now available across all UK nations

New phase of development targets chronic pain and fibromyalgia New phase of development targets chronic pain and fibromyalgia

Klick Media’s President shares his perspective on how AI is redefining planning, analytics and micro-segmentation in HCP marketing

65% of HCP digital interactions lead nowhere. Learn 5 customer journey orchestration tactics to transform static pharma websites into dynamic experien...

DTC isn’t converting to Rxs at the pharmacy. Learn how access may be key to your brand’s success.